Cannabis Press Releases

Cannabis press releases from around the world and United States. Covering marijuana, hemp, and CBD news for pro cannabis media services.

Latest Cannabis Press Releases News

Zoned Properties Invests in AnamiTech & GreenSpace PropTech Platform

Exploring Strategic Partnership with AnamiTech to Collaborate on Servicing Cannabis Real Estate

Business Wire Business Wire

Texas Original Opens Drive-Thru Medical Cannabis Pickup Location in Waco, Texas

AUSTIN, Texas--(BUSINESS WIRE)--Texas Original, Texas’ leading medical cannabis provider, announced its newest

Business Wire Business Wire

Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK

LONDON--(BUSINESS WIRE)--#akanda--Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical

Business Wire Business Wire

Virpax Will Pursue Direct to OTC Pathway for Epoladermâ„¢ for Pain Associated with Osteoarthritis

BERWYN, Pa.--(BUSINESS WIRE)--#pharma--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a

Business Wire Business Wire

WM Technology, Inc. Joins Russell 3000®, Russell 2000® and Russell Microcap® Indexes

IRVINE, Calif.--(BUSINESS WIRE)--$MAPS--WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS),

Business Wire Business Wire

Leafly Set to Join Russell 3000® and Russell 2000® Index

SEATTLE--(BUSINESS WIRE)--Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), is set

Business Wire Business Wire

Proposed Settlement Reached in 2016 Class Action

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram

Business Wire Business Wire

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

TORONTO--(BUSINESS WIRE)--Akanda Corp. ("Akanda" or the "Company") today announced certain changes to

Business Wire Business Wire

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing

Business Wire Business Wire